{"id":1464,"date":"2003-10-01T12:02:00","date_gmt":"2003-10-01T10:02:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2003\/die-britische-million-women-study-bestaetigt-assoziation-von-hrt-und-brustkrebs"},"modified":"2003-10-01T12:02:00","modified_gmt":"2003-10-01T10:02:00","slug":"die-britische-million-women-study-bestaetigt-assoziation-von-hrt-und-brustkrebs","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2003\/die-britische-million-women-study-bestaetigt-assoziation-von-hrt-und-brustkrebs","title":{"rendered":"Die britische Million Women Study best\u00e4tigt Assoziation von &#8222;HRT&#8220; und Brustkrebs."},"content":{"rendered":"<p>In den letzten Jahren haben wir uns in einem Hauptartikel (1), mehreren Kurzmitteilungen (2) und Leserbriefen (3) mit dem Thema \u201dHormonersatz-Therapie\u201d (HRT) bei postmenopausalen Frauen und Brustkrebs auseinandergesetzt. Die letzte Meldung betraf die amerikanische Women&#8217;s Health Initiative (WHI) Study, die bisher gr\u00f6\u00dfte randomisiert-prospektive Studie an \u00fcber 16000 Frauen, in der eine Steigerung der Brustkrebs-Inzidenz um [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In den letzten Jahren haben wir uns in einem Hauptartikel (1), mehreren Kurzmitteilungen (2) und Leserbriefen (3) mit dem Thema \u201dHormonersatz-Therapie\u201d (HRT) bei postmenopausalen Frauen und Brustkrebs auseinandergesetzt. Die letzte Meldung betraf die amerikanische Women&#8217;s Health Initiative (WHI) Study, die bisher gr\u00f6\u00dfte randomisiert-prospektive Studie an \u00fcber 16000 Frauen, in der eine Steigerung der Brustkrebs-Inzidenz um [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[59,57,358,363,360,364,357,362,1952,62,66,359],"class_list":["post-1464","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-estrogene","tag-estrogene-gestagene","tag-het","tag-hormonersatz-therapie","tag-hormonersatztherapie","tag-hrt","tag-klimakterium","tag-menopause","tag-million-women-study","tag-oestrogene","tag-oestrogene-gestagene","tag-postmenopause"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1464"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1464\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1464"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1464"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}